Arcturus Therapeutics (ARCT) PT Lowered to $31 at Barclays

November 9, 2021 4:55 AM EST Send to a Friend

Barclays analyst Gena Wang lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Arcturus Therapeutics (ARCT) PT Lowered to $31 at Barclays

Member Login

Free News Feed